Biome Australia Ltd (ASX: BIO) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Biome Australia Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$117.23 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
219.12 million
Earnings per share
-0.008
Dividend per share
N/A
Year To Date Return
165.85%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Biome Australia Ltd (ASX: BIO)
Latest News
Small Cap Shares
Guess which small cap ASX stock could rise 45%
IPOs
The Biome Australia (ASX: BIO) share price just flopped on IPO
BIO ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Biome Australia Ltd
Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals food-based vitamins and weight management products and live biotherapeutics. The firm owns brands namely; Activated Nutrients: a range of completely organic, plant-based, all-in-one nutritional products; Activated Probiotics: a first-of-its-kind range of clinically-backed precision probiotics. The company has one operating segment: researching, developing, manufacturing and distributing innovative evidence-based products linking the gut and human health. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners.
BIO Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 24 Dec 2024 | $0.54 | $-0.01 | -1.83% | 516,820 | $0.54 | $0.58 | $0.54 |
| 23 Dec 2024 | $0.55 | $0.03 | 5.83% | 190,968 | $0.52 | $0.55 | $0.51 |
| 20 Dec 2024 | $0.52 | $-0.05 | -8.85% | 319,016 | $0.57 | $0.57 | $0.52 |
| 19 Dec 2024 | $0.57 | $0.02 | 3.70% | 630,380 | $0.56 | $0.58 | $0.53 |
| 18 Dec 2024 | $0.54 | $0.01 | 1.89% | 312,899 | $0.54 | $0.57 | $0.53 |
| 17 Dec 2024 | $0.53 | $0.03 | 5.94% | 420,355 | $0.51 | $0.54 | $0.50 |
| 16 Dec 2024 | $0.51 | $-0.02 | -3.81% | 285,080 | $0.53 | $0.54 | $0.51 |
| 13 Dec 2024 | $0.53 | $0.02 | 3.92% | 385,400 | $0.52 | $0.53 | $0.52 |
| 12 Dec 2024 | $0.51 | $-0.02 | -3.81% | 448,193 | $0.53 | $0.55 | $0.50 |
| 11 Dec 2024 | $0.53 | $0.00 | 0.00% | 119,263 | $0.52 | $0.54 | $0.52 |
| 10 Dec 2024 | $0.53 | $0.01 | 1.92% | 392,007 | $0.53 | $0.54 | $0.50 |
| 09 Dec 2024 | $0.52 | $-0.01 | -1.89% | 776,859 | $0.54 | $0.55 | $0.52 |
| 06 Dec 2024 | $0.53 | $-0.03 | -5.36% | 514,466 | $0.56 | $0.56 | $0.53 |
| 05 Dec 2024 | $0.56 | $0.00 | 0.00% | 424,296 | $0.56 | $0.57 | $0.55 |
| 04 Dec 2024 | $0.56 | $0.00 | 0.00% | 121,210 | $0.56 | $0.56 | $0.55 |
| 03 Dec 2024 | $0.56 | $0.02 | 3.67% | 197,914 | $0.55 | $0.57 | $0.55 |
| 02 Dec 2024 | $0.55 | $-0.02 | -3.54% | 580,722 | $0.57 | $0.59 | $0.54 |
| 29 Nov 2024 | $0.57 | $-0.02 | -3.45% | 335,681 | $0.59 | $0.59 | $0.56 |
| 28 Nov 2024 | $0.58 | $0.00 | 0.00% | 316,053 | $0.58 | $0.61 | $0.57 |
| 27 Nov 2024 | $0.58 | $0.01 | 1.75% | 719,523 | $0.62 | $0.62 | $0.57 |
| 26 Nov 2024 | $0.57 | $0.02 | 3.64% | 151,815 | $0.56 | $0.58 | $0.56 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 29 Nov 2024 | Geoffrey Sam | Buy | 85,735 | $49,974 |
On-market trade.
|
| 28 Nov 2024 | Ilario Faenza | Buy | 17,000 | $10,226 |
On-market trade.
|
| 27 Nov 2024 | Blair Norfolk | Buy | 100,000 | $59,571 |
On-market trade.
|
| 27 Nov 2024 | Dominique Fisher | Buy | 45,000 | $26,387 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Ms Dominique Gayle Fisher | Non-Executive Director | Aug 2021 |
Ms Fisher couples her experience in tech driven businesses with a focus on risk mitigation and financial management which has led to her working in across a range of sectors in executive and non-executive roles. She has Audit, Remuneration and Risk Committee experience of listed and unlisted companies. She has also served on government and private advisory boards at state and federal for major political parties, Geoscape Australia and government agencies including the Sydney Opera House, Australia Post and the Australian Council for the Arts. She is Chair of Risk Committee.
|
| Mr Geoffrey Joseph Sam | Non-Executive Director | Nov 2024 |
Mr Sam building from his background in hospital executive leadership, Geoff co-founded Healthecare
Australia Pty Ltd in 2005. Healthecare Australia is a privately owned healthcare company comprising a portfolio of 17 private hospitals and employing nearly 5,000 healthcare professionals nationwide. He currently serves as a Non-Executive Director of IDT Ltd, Change Financial Ltd and EarlyPay Ltd. His past board positions include ParagonCare Ltd, Money 3 Ltd, Hutchinsons Childcare Services Ltd and Nova Health Ltd. |
| Mr Ilario Faenza | Non-Executive ChairmanNon-Executive Director | Aug 2020 |
Mr Faenza is M&A, PE & investment banking specialist with over 30 years of experience in a range of industries. Ilario has started companies and provided advisory, specialist M&A, due diligence, structuring and fund raising assistance to businesses. Ilario has raised > $100M over the past 15 years for growth companies and assists management with execution of strategy, commercial negotiations, IPO's and exit strategies. Other current directorships include Harvest Technology Group Limited (appointed 29 January 2024). He is Member of Risk Committee.
|
| Mr Blair Vega Norfolk | Chief Executive OfficerManaging Director | Jul 2018 |
Mr Norfolk is a experience as management and executive. Since founding the business, Blair has recruited the people, secured funding, products and IP and managed key relationships. Blair has relationships in media, pharmacy, research and manufacturing. Blair has a public profile as a health advocate and speaks at conferences and panels from mental health to general wellbeing. He is member of Risk Committee.
|
| Mr George Lazarou | Company Secretary |
-
|
|
| Douglas Chee Yong Loh | Chief financial officer |
-
|
|
| George Lazarou | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Ocean And Remi Pty Ltd <Cambria Partners A/C> | 18,209,955 | 8.31% |
| Raymond Demaio Pty Ltd <Raymond Demaio Family A/C> | 12,000,000 | 5.48% |
| Cob Pty Ltd | 7,907,419 | 3.61% |
| Emmanuel Investment Holdings Pty Ltd <Loh Family A/C> | 6,102,010 | 2.78% |
| DC Retirement Nominees Pty Ltd <Dc Family Trust A/C> | 4,523,728 | 2.06% |
| Burrangong Pty Ltd <Sam Family Settlement A/C> | 3,797,101 | 1.73% |
| Mrs Aini Loh | 3,336,883 | 1.52% |
| National Nominees Limited | 3,102,699 | 1.42% |
| Astro Superannuation Holdings Pty Ltd <Emmanuel Super Fund A/C> | 2,865,787 | 1.31% |
| See Breeze Consulting Pty Ltd | 2,823,405 | 1.29% |
| Mr Yuk Chung Edward Chiu | 2,769,565 | 1.26% |
| Evergem Pty Ltd <The Evergem Unit A/C> | 2,752,214 | 1.26% |
| Netwealth Investments Limited <Wrap Services A/C> | 2,739,644 | 1.25% |
| Mr Joshua Oliver Stanford-Harris | 2,583,466 | 1.18% |
| Mr Paul James Madden | 2,547,741 | 1.16% |
| Carlisle And Co Pty Ltd <Wattle Superfund A/C> | 2,265,000 | 1.03% |
| Mr John William Bronger | 2,140,579 | 0.98% |
| CG Nominees (Australia) Pty Ltd | 2,000,000 | 0.91% |
| Qintet Pharma Partners Pty Ltd | 2,000,000 | 0.91% |
| Kyriaco Barber Pty Ltd | 1,900,000 | 0.87% |
| Chemistworx Management Pty Ltd <Bronger Superannuation Fund A/C> | 1,630,434 | 0.74% |
